EMX Royalty Corp
SWB:6E9
EMX Royalty Corp
SWB:6E9
Price:
3.46
EUR
Market Cap:
€388.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
EMX Royalty Corp
SWB:6E9
|
CA |
|
Corcept Therapeutics Inc
LSE:0I3Q
|
US |
|
CompuGroup Medical SE & Co KgaA
F:COPA
|
DE |
|
S
|
Swedbank AB
SWB:FRYA
|
SE |
|
M
|
MLP SE
DUS:MLP
|
DE |
|
O
|
O'Reilly Automotive Inc
XMUN:OM6
|
US |
|
R
|
Robert Half Inc
DUS:RHJ
|
US |
|
A
|
Adobe Inc
SWB:ADB
|
US |
|
Metro AG
XETRA:B4B
|
DE |
|
H
|
HKScan Oyj
SWB:HK4
|
FI |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
H
|
Hexpol AB
SWB:4QT1
|
SE |
|
S
|
Sofina SA
LSE:0G2X
|
BE |
|
F
|
Fincanna Capital Corp
CNSX:CALI.X
|
CA |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
Rupert Resources Ltd
XTSX:RUP
|
CA |
|
Benitec Biopharma Inc
NASDAQ:BNTC
|
US |
|
S
|
Sumitomo Corp
XMUN:SUMA
|
JP |
|
Abivax SA
PAR:ABVX
|
FR |
|
HLS Therapeutics Inc
TSX:HLS
|
CA |
|
T
|
Texas Instruments Inc
DUS:TII
|
US |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
Q
|
Quest Diagnostics Inc
SWB:QDI
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EMX Royalty Corp's stock price target?
Not Available
EMX Royalty Corp does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for EMX Royalty Corp?
Projected CAGR
9%
9%
Over the last 12 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 3 years is 9%.
